The program will also work to increase access to chemotherapy and provide essential emotional support services for patients navigating their cancer journey.
This strategic shift addresses mounting concerns about regulatory compliance and workforce development in the country’s healthcare sector.
The Pharmacy and Poisons Board has approved both the 300 mg tablet and 464 mg injectable solution forms of Lenacapavir for use as pre-exposure prophylaxis (PrEP).
The newly accredited program will deliver an extensive curriculum covering trauma and emergency management, sports injuries, joint replacement surgeries, and pediatric orthopedic care.
The Lions Hope Center represents a collaborative effort between Kenyatta National Hospital, the Lions Clubs International Foundation (LCIF), and the Kasigau Students Education Fund (KSEF).
The summit takes place in New Delhi from December 17 to 19 and will showcase India’s extensive experience in traditional and complementary medicine.
The funding will focus on preventing and managing diseases such as HIV/AIDS, tuberculosis (TB), and malaria, as well as improving maternal and child health, eradicating polio, strengthening disease surveillance, and enhancing preparedness for infectious disease outbreaks.
Results showed that the injectable regimen performed just as well as the daily oral dolutegravir-based therapy (TLD) but helped reduce the burden of daily medication.
CS Duale demanded the swift removal of all substandard, falsified, poor-quality, counterfeit, and unregistered medicines from the Kenyan market.